Nausea and vomiting symptoms related to postoperative liver cancer interventional treatment.
Conditions
Interventions
Evidence Application Group:Non-pharmacological intervention
Evidence Application Group:Routine Nursing Care for Nausea and Vomiting after Hepatocellular Carcinoma Interventional Surgery
Sponsors
The affiliated hospital of southwest medical university
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years old; 2. Patients diagnosed with primary liver cancer by medical examination and undergoing TACE treatment for the first time; 3. Capable of normal communication and interaction; 4. Patients voluntarily sign the informed consent form for this study.
Exclusion criteria
Exclusion criteria: 1. Patients with concurrent splenic embolization or undergoing TACE combined with radiofrequency ablation treatment; 2. Patients with other diseases that may cause nausea and vomiting, such as biliary obstruction, intestinal obstruction, etc.; 3. Patients with severe cardiopulmonary diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence and severity of nausea and vomiting; | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of chemotherapy-induced nausea and vomiting;Quality of Life ;Number of additional cases of remedial medication;Occurrence of adverse events;patient satisfaction;Nurse execution rate;Nurse nausea and vomiting knowledge level score; | — |
Countries
China
Contacts
Public ContactZheng Silin
The affiliated hospital of southwest medical university
Outcome results
None listed